Copyright © 2005, European Society of Cardiology
Functional effects of protein kinase C-mediated myofilament phosphorylation in human myocardium
aLaboratory for Physiology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands
bDepartment of Cardiology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands
cUDMHSC, Division of Clinical Physiology, Institute of Cardiology, Debrecen, Hungary
dForschungslabor Molekulare Kardiologie, St. Josef Hospital, Klinik der Ruhr-Universität, Bochum, Germany
* Corresponding author. Laboratory for Physiology, Institute for Cardiovascular Research, VU University Medical Center, van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands. Tel.: +31 20 4448113; fax: +31 20 4448255. Email address: j.vandervelden{at}vumc.nl
Objective: In human heart failure β-adrenergic-mediated protein kinase A (PKA) activity is down-regulated, while protein kinase C (PKC) activity is up-regulated. PKC-mediated myofilament protein phosphorylation might be detrimental for contractile function in cardiomyopathy. This study was designed to reveal the effects of PKC on myofilament function in human myocardium under basal conditions and upon modulation of protein phosphorylation by PKA and phosphatases.
Methods: Isometric force was measured at different [Ca2+] in single permeabilized cardiomyocytes from non-failing and failing human left ventricular tissue. Basal phosphorylation of myofilament proteins and the influence of PKC, PKA, and phosphatase treatments were analyzed by one- and two-dimensional gel electrophoresis, Western immunoblotting, and ELISA.
Results: Troponin I (TnI) phosphorylation at the PKA sites was decreased in failing compared to non-failing hearts and correlated well with myofilament Ca2+ sensitivity (pCa50). Incubation with the catalytic domain of PKC slightly decreased maximal force under basal conditions, but not following PKA and phosphatase pretreatments. PKC reduced Ca2+ sensitivity to a larger extent in failing (
pCa50=0.19 ± 0.03) than in non-failing (
pCa50=0.08 ± 0.01) cardiomyocytes. This shift was reduced, though still significant, when PKC was preceded by PKA, while PKA following PKC did not further decrease pCa50. Protein analysis indicated that PKC phosphorylated PKA sites in human TnI and increased phosphorylation of troponin T, while myosin light chain phosphorylation remained unaltered.
Conclusion: In human myocardium PKC-mediated myofilament protein phosphorylation only has a minor effect on maximal force development. The PKC-mediated decrease in Ca2+ sensitivity may serve to improve diastolic function in failing human myocardium in which PKA-mediated TnI phosphorylation is decreased.
KEYWORDS Protein kinase C; Heart failure; Myofilament function; Protein phosphorylation
Time for primary review 20 days
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Molnar, A. Borbely, D. Czuriga, S. M. Ivetta, S. Szilagyi, Z. Hertelendi, E. T. Pasztor, A. Balogh, Z. Galajda, T. Szerafin, et al. Protein Kinase C Contributes to the Maintenance of Contractile Force in Human Ventricular Cardiomyocytes J. Biol. Chem., January 9, 2009; 284(2): 1031 - 1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yuan, Q. Sheng, H. Tang, Y. Li, R. Zeng, and R. J. Solaro Quantitative comparison of sarcomeric phosphoproteomes of neonatal and adult rat hearts Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H647 - H656. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hamdani, V. Kooij, S. van Dijk, D. Merkus, W. J. Paulus, C. d. Remedios, D. J. Duncker, G. J.M. Stienen, and J. van der Velden Sarcomeric dysfunction in heart failure Cardiovasc Res, March 1, 2008; 77(4): 649 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Davis and S. B. Tikunova Ca2+ exchange with troponin C and cardiac muscle dynamics Cardiovasc Res, March 1, 2008; 77(4): 619 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Hanft, F. S. Korte, and K. S. McDonald Cardiac function and modulation of sarcomeric function by length Cardiovasc Res, March 1, 2008; 77(4): 627 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Belin, M. P. Sumandea, E. J. Allen, K. Schoenfelt, H. Wang, R. J. Solaro, and P. P. de Tombe Augmented Protein Kinase C-{alpha}-Induced Myofilament Protein Phosphorylation Contributes to Myofilament Dysfunction in Experimental Congestive Heart Failure Circ. Res., July 20, 2007; 101(2): 195 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Neulen, N. Blaudeck, S. Zittrich, D. Metzler, G. Pfitzer, and R. Stehle Mn2+-dependent protein phosphatase 1 enhances protein kinase A-induced Ca2+ desensitisation in skinned murine myocardium Cardiovasc Res, April 1, 2007; 74(1): 124 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Narolska, N. Piroddi, A. Belus, N. M. Boontje, B. Scellini, S. Deppermann, R. Zaremba, R. J. Musters, C. dos Remedios, K. Jaquet, et al. Impaired Diastolic Function After Exchange of Endogenous Troponin I With C-Terminal Truncated Troponin I in Human Cardiac Muscle Circ. Res., October 27, 2006; 99(9): 1012 - 1020. [Abstract] [Full Text] [PDF] |
||||



